NCT04575857View on ClinicalTrials.gov

Role of Statins In Slowing Rheumatic Heart Disease (RHD) Progression

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

February 29, 2040

Study Completion Date

February 29, 2040

Conditions
Rheumatic Heart DiseaseValvular Disease
Interventions
DRUG

Atorvastatin

Participants in the intervention arm will receive a pill packet with atorvastatin (40mg) x 18 months.

DRUG

Placebo

Participants in the control arm will receive a pill packet with placebo x 18 months.

Trial Locations (1)

Unknown

Manmohan Memorial Medical College & Teaching Hospital., Kathmandu

All Listed Sponsors
collaborator

Manmohan Cardiothoracic Vascular and Transplant Center

UNKNOWN

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Washington

OTHER